• Explore /
  • Poster
  • / Phase I open label trial of intraperitoneal paclitaxel (IPP) in combination with intravenous cisplatin (C) and oral capecitabine (X) in patients with advanced gastric cancer and peritoneal metastases.

Phase I open label trial of intraperitoneal paclitaxel (IPP) in combination with intravenous cisplatin (C) and oral capecitabine (X) in patients with advanced gastric cancer and peritoneal metastases.

Abstract Poster

Authors

null

Sina Vatandoust

Flinders University Medical Centre, Adelaide, Australia

Sina Vatandoust , Tim I. Bright , Amitesh Chandra Roy , Myron Klevansky , Jeff Bull , Christos Stelios Karapetis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

ACTRN12614001063606

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS201)

DOI

10.1200/JCO.2018.36.4_suppl.TPS201

Abstract #

TPS201

Poster Bd #

M15

Abstract Disclosures

Similar Posters

First Author: Sina Vatandoust

First Author: Josep Tabernero

First Author: Yelena Y. Janjigian

First Author: Ursula Wiedermann